TCL Archive Slow Accruing Trials Should Be Removed From High Priority Program, Broder Says October 2, 1992
TCL Archive Iniparib Doesn’t Meet Survival, PFS Endpoints In Phase III Trial in Triple-Negative Breast Cancer February 25, 2011